175Yb labeled polyaminophosphonates as potential agents for bone pain palliation
Authors:
- Tapas DasTDTapas Das
- H.D SarmaHSH.D Sarma
- M.R.A PillaiMPM.R.A Pillai
- 1 May 2004
- journal article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 60 (5) , 635-642
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Feasibility study for production of 175Yb: a promising therapeutic radionuclideApplied Radiation and Isotopes, 2002
- 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliationApplied Radiation and Isotopes, 2002
- 177Lu labelled polyaminophosphonates as potential agents for bone pain palliationNuclear Medicine Communications, 2002
- Tc-99m and Re-186 complexes of tetraphosphonate ligands and their biodistribution pattern in animal modelsNuclear Medicine and Biology, 2001
- Production of 105Rh–EDTMP and its bone accumulationApplied Radiation and Isotopes, 2000
- Preparation, stability studies and pharmacological behavior of [186Re]Re–HEDPApplied Radiation and Isotopes, 1999
- 177Lu-EDTMPNuclear Medicine Communications, 1998
- Overview of nuclides for bone pain palliationApplied Radiation and Isotopes, 1998
- Coordination compounds in nuclear medicineChemical Reviews, 1993
- Radiopharmaceuticals for palliation of metastatic osseous lesions: Biologic and physical backgroundSeminars in Nuclear Medicine, 1992